Microbiology

Neonatal Skin: Structure and Function, Second Edition, Revised and Expanded

Volumn , Issue , 2003, Pages 21-46

  Sidbury, Robert ^a   Darmstadt, Gary L ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b SAVE THE CHILDREN   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84911147220     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (164)

1. Galen WK, Fischer G, Darmstadt GL. Bacterial infections. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology. New York: Churchill Livingstone, 2002; in press.
2. Nopper AJ, Horii KA, Sookdeo-Drost S, Wang TH, Mancini AJ, Lane AT. Topical ointment therapy benefits premature infants. J Pediatr 1996; 128:660-669.
3. Rowen JL, Atkins JT, Levy ML, Baer SC, Baker CJ. Invasive fungal dermatitis in the <1000 gram neonate. Pediatrics 1995; 95:682-688.
4. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, Fanaroff AA, Lemons JA, Donovan EF, Oh W, Stevenson DK, Ehrenkranz RA, Papile LA, Verter J, Wright LL. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129:63-71.
5. Bartlett AV, Paz de Bocaletti ME, Bocaletti MA. Neonatal and early postneonatal morbidity and mortality in a rural Guatemalan community: the importance of infectious diseases and their management. Pediatr Infect Dis J 1991; 10:752-757.
6. Stoll BJ. The global impact of neonatal infection. Clin Perinatol 1997; 24:1-21.
7. Sarkany I, Gaylarde CC. Bacterial colonization of the skin of the newborn. J Pathol Bacteriol 1968; 95:115-122.
8. Winram SB, Jonas M, Chi E, Rubens CE. Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells In vitro. Infect Immun 1998; 66(10):4932-4941.
9. Darmstadt GL, Dinulos JG, Miller Z. Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines. Pediatrics 2000; 105:438-444.
10. Evans HE, Akpata SO, Baki A. Factors influencing the establishment of the neonatal bacterial flora. I. The role of host factors. Arch Environ Health 1970; 21:514-519.
11. Rotimi VO, Olowe SA, Ahmed I. The development of bacterial flora of premature infants. J Hyg 1985; 94:309-318.
12. Leyden JJ. Bacteriology of newborn skin. In: Maibach H, Boisits EK, eds. Neonatal Skin: Structure and Function. New York: Marcel Dekker, 1982:167-181.
13. Sacks LM, McKitrick JC, MacGregor RR. Surface cultures and isolation procedures in infants born under unsterile conditions. Am J Dis Child 1983; 137:251-353.
14. Rotimi VO, Duerden BI. The development of the bacterial flora in normal neonates. J Med Microbiol 1981; 14:51-62.
15. D’Angio CT, McGowan KL, Baumgart S, St. Geme J, Harris MC. Surface colonization with coagulase-negative staphylococci in premature neonates. J Pediatr 1989; 114:1029-1034.
16. Mackowiak PA. The normal microbial flora. N Engl J Med 1982; 307:83-93.
17. Eastick K, Leeming JP, Bennett D, Millar MR. Reservoirs of coagulase negative staphylococci in preterm infants. Arch Dis Child 1996; 74:F99-104.
18. Darmstadt GL. Staphylococcal and streptococcal skin infections. In: Harahap M, ed. Diagnosis and Treatment of Skin Infections. Oxford: Blackwell Scientific Publ. 1997; 7-115.
19. Roth RR, James WD. Microbiology of the skin: resident flora, ecology, infection. J Am Acad Dermatol 1989; 20:367-390.
20. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997; 387(6636):861.
21. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA. Inducible expression of human beta-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 2000; 68:2907-2915.
22. Dinulos JG, Mentele L, Fredericks LP, Dale BA, Darmstadt GL. Keratinocyte expression of human beta-defensin-2 following bacterial infection: role in cutaneous host defense. Clin Lab Diag Immunol 2002; in press.
23. Darmstadt GL, Dinulos JG. Bacterial infections. In: Eichenfield LF, Frieden IJ, Esterly NB, eds. Textbook of Neonatal Dermatology. Philadelphia: WB Saunders. 2000:177-198.
24. Evans NJ, Rutter N. Development of the epidermis in the newborn. Biol Neonate 1986; 49:74-80.
25. Leyden JJ. Bacterial colonization of the skin of the newborn. In: Polin RA, Fox WW, eds. Fetal and Neonatal Physiology. Vol. 2. 2d ed. Philadelphia: WB Saunders Co., 1998:788-791.
26. Bertone SA, Fisher MC, Mortensen JE. Quantitative skin cultures at potential catheter sites in neonates. Infect Control Hosp Epidemiol 1994; 15:315-318.
27. Bhatia BD, Chug S, Narang P, Singh MN. Bacterial flora of newborns at birth and 72 hours of age. Indian Pediatr 1988; 25:1058-1065.
28. Ghosh S, Chatterjee BD, Chakraborty CK, Chakravarty A, Khatua SP. Bacteria in surface infections in neonates. J Indian Med Assoc 1995; 93:132-135.
29. Goldmann DA, Leclair J, Macone A. Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr 1978; 93:288-293.
30. Evans HE, Akpata SO, Baki A. Factors influencing the establishment of the neonatal bacterial flora. II. The role of environmental factors. Arch Environ Health 1970; 21(5):643-648.
31. Evans ME, Schaffner W, Federspiel CF, Cotton RB, McKee KT, Stratton CW. Sensitivity, specificity, and predictive value of body surface cultures in a neonatal intensive care unit. JAMA 1988; 259:248-252.
32. Sprunt K, Leidy G, Redman W. Abnormal colonization of neonates in an intensive care unit: means of identifying neonates at risk of infection. Pediatr Res 1978; 12:998-1002.
33. Savey A, Fleurette J, Salle BL. An analysis of the microbial flora of premature neonates. J Hosp Infect 1992; 21:275-289.
34. Keyworth N, Millar MR, Holland KT. Development of cutaneous microflora in premature infants. Arch Dis Child 1992; 67:797-801.
35. Dajani AS, Ferrieri P, Wannamaker LW. Natural history of impetigo. II. Etiologic agents and bacterial interactions. J Clin Invest 1972; 51:2863-2871.
36. Ferrieri P, Dajani AS, Wannamaker LW, Chapman SS. Natural history of impetigo. I. Site sequence of aquisition and familial patterns of spread of cutaneous streptococci. J Clin Invest 1972; 51:2851-2862.
37. Darmstadt GL, Fleckman P, Jonas M, Chi E, Rubens CE. Differentiation of cultured keratinocytes promotes adherence of Streptococcus pyogenes. J Clin Invest 1998; 101:128-136.
38. Darmstadt GL, Fleckman P, Rubens CE. TNF-α and IL-1α decrease adherence of Streptococcus pyogenes to keratinocytes. J Infect Dis 1999; 180:1718-1721.
39. Darmstadt GL, Fleckman P, Rubens CE. Role of keratinocyte injury in adherence of Streptococcus pyogenes. Infect Immun 1999; 67:6707-6709.
40. Darmstadt GL, Mentele L, Podbielski A, Rubens CE. Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun 2000; 68:1215-1221.
41. Joglekar VM. Barrier properties of vernix caseosa. Arch Dis Child 1980; 55:817-819.
42. Kitzmiller JL, Highby S, Lucal WE. Retarded growth of E. coli in amniotic fluid. Obstet Gynecol 1973; 41:38-42.
43. Lubinski H, Benjamin B. Effect of vernix caseosa on bacteria. CMAJ 1941; 171-173.
44. Sprunt K, Redman WM. Vernix caseosa and bacteria. Am J Dis Child 1964; 107:125-130.
45. Hoath SB. The stickiness of newborn skin: bioadhesion and the epidermal barrier. J Pediatr 1997; 131:338-340.
46. Okah FA, Wickett R, Pompa K, Hoath SB. Human newborn skin: the effect of isopropanol on skin surface hydrophobicity. Pediatr Res 1994; 35:443-446.
47. Lund C, Kuller J, Lane A, Lott JW, Raines DA. Neonatal skin care: the scientific basis for practice. J Obstet Gynecol Neonatal Nurs 1999; 28:241-254.
48. Meneghini CL. Some guidelines in neonatal skin care. Eur J Pediatr Dermatol 1998; 8:229-232.
49. Darmstadt GL, Mao-Qiang M, Saha SK, Ziboh VA, Black RE, Santosham M, Elias PM. Impact of topical oils on the skin barrier: possible implications for neonatal health in developing countries. Acta Paediatr 2002; 91:1-9.
50. Pabst RC, Starr KP, Qaiyumi S, Schwalbe RS, Gewolb IH. The effect of application of aquaphor on skin condition, fluid requirement, and bacterial colonization in very low birth weight infants. J Perinatol 1999; 19:278-283.
51. Wallace M, Lindado S, Bedrick A et al: Aquaphor as a source of colonization and subsequent bloodstream infections among very low birthrate neonates (abstr). Infect Control Hosp Epidemiol 1998; 19:689.
52. Edwards WH, Conner JM, Soll RF. The effect of Aquaphor original emollient ointment on nosocomial sepsis rates and skin integrity in infants of birth weight 501 to 1000 grams (abstr). Pediatr Res 2001; 49(4) (suppl):2330.
53. Darmstadt GL, Lane AT. Impetigo: an overview. Pediatr Dermatol 1994; 4:293-303.
54. Dale JB, Washburn RG, Marques MB, Wessels MR. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun 1996; 64:1495-1501.
55. Engleberg NC, Heath A, Miller A, Rivera C, DeRita VJ. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Inf Dis 2001; 183:1043-1054.
56. Ashbaugh CD, Warren HB, Carey VJ, Wessels MR. Molecular analysis of the role of group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest 1998; 102:550-560.
57. Ferrieri P. Microbiological features of current virulent strains of group A streptococci. Pediatr Infect Dis J 1991; 10:S20-S24.
58. van de Rijn I, Bernish B, Crater DL. Analysis of hyaluronic acid capsule expression in group A streptococci. Adv Exp Med Biol 1997; 418:965-969.
59. Jonas M, Darmstadt GL, Rubens CE, Chi EY. Ultrastructure of invasion of group A streptococcus into human keratinocytes. Proc 14th Int Congr Electron Microscopy 1998; 4:375-376.
60. Bessen DE, Carapetis JR, Beall B, Katz R, Hibble M, Currie BJ, Collingridge T, Izzo MW, Scaramuzinno DA, Sriprakash KS. Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of skin and throat. J Infect Dis 2000; 182:1109-1116.
61. Bessen DE, Sotir CM, Readdy TL, Hollingshead SK. Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis 1996; 173:896-900.
62. Svensson MD, Scaramuzzino DA, Sjobring U, Olsen A, Frank C, Bessen DE. Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci. Mol Microbiol 2000; 38:242-253.
63. Miller SJ, Aly R, Shinefield HR, Elias PM. In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol 1988; 124:209-215.
64. Ushijima T, Takahashi M, Ozaki Y. Acetic, propionic, and oleic acid as the possible factors influencing the predominant residence of some species of Propionibacterium and coagulase negative Staphylococcus on normal human skin. Can J Microbiol 1984; 30:647-652.
65. Gallo RL, Huttner KM. Antimicrobial peptides: an emerging concept in cutaneous biology. J Invest Dermatol 1998; 111:739-743.
66. Nizet V, Ohtake T, Lauth X, Trowbridge J, Rudisill J, Dorschner RA, Pestonjamasp V, Piraino J, Huttner K, Gallo RL. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001; 414:454-457.
67. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizat V, Agerberth B, Gudmundsson GH, Gallo RL. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001; 117:91-97.
68. Dale B, Kimball J, Krisanaprakornkit S, Roberts F, Robinovitch M, O’Neal R, Valore EV, Ganz T, Anderson GM, Weinberg A. Localized antimicorbial peptide expression in human gingiva. J Periodont Res 2001; 36:285-294.
69. Nickoloff BJ, Griffiths CEM, Barker JNMN. The role of adhesion molecules, chemotactic factors and cytokines in inflammatory and neoplastic skin disease—1990 update. J Invest Dermatol 1990; 94:151S-157S.
70. Kupper TS, Groves RW. The interleukin-1 axis and cutaneous inflammation. J Invest Dermatol 1995; 105:62S-66S.
71. Molne L, Verdrengh M, Tarkowski A. Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun 2000; 68:6162-6167.
72. Molne L, Tarkowski A. An experimental model of cutaneous infection induced by superantigen-producing Staphylococcus aureus. J Invest Dermatol 2000; 114:1120-1125.
73. Limbago B, Penumalli V, Weinrick B, Scott JR. Role of streptolysin O in a mouse model of invasive group A streptococcal disease. Infect Immun 2000; 68:6384-6390.
74. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR. Toxin in bullous impetigo and staphylococcal scalded skin syndrome targets desmoglein 1. Nat Med 2000; 6:1275-1277.
75. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996; 334:240-245.
76. Stevens DL. Invasive group A streptococcal infections: the past, present and future. Pediatr Infect Dis J 1994; 13:561-566.
77. Eriksson BKG, Andersson J, Holm SE, Norgren M. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. J Infect Dis 1999; 180:410-418.
78. Stamenkovic I, Lew PD. Early recognition of potentially fatal necrotizing fasciitis. N Engl J Med 1972; 310:1689-1693.
79. Barker FG, Leppard BJ, Seal DV. Streptococcal necrotizing fasciitis: comparison between histological and clinical features. J Clin Pathol 1987; 40:335-341.
80. Brook I, Frazier EH. Clinical and microbiological features of necrotizing fasciitis. J Clin Microbiol 1995; 33:2382-2387.
81. Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14:2-13.
82. Brook I. The role of encapsulated anaerobic bacteria in synergistic infections. FEMS Microbiol Rev 1994; 13:65-74.
83. Kingston D, Seal DV. Current hypotheses on synergistic microbial gangrene. Br J Surg 1990; 77:260-264.
84. Nachman RL, Esterly NB. Increased skin permeability in preterm infants. J Pediatr 1971; 79:628-632.
85. Hammarlund K, Sedin G. Transepidermal water loss in newborn infants. III. Relation to gestational age. Acta Paediatr Scand 1979; 68:795-801.
86. Rutter N, Hull D. Water loss from the skin of term and preterm babies. Arch Dis Child 1979; 54:858-868.
87. Harpin VA, Rutter N. Barrier properties of the newborn infant’s skin. J Pediatr 1983; 102:419-425.
88. Barker N, Hadgraft J, Phil D, Rutter N. Skin permeability in the newborn. J Invest Dermatol 1987; 88:409-411.
89. Bautista MIB, Wickett RR, Visscher MO, Pickens WL, Hoath SB. Characterization of vernix caseosa as a natural biofilm: comparison to standard oil-based ointments. Pediatr Dermatol 2000; 17:253-260.
90. Lane AT. Development and care of the premature infant’s skin. Pediatr Dermatol 1987:41-5.
91. St. Geme JI. Staphylococcus epidermidis and other coagulase-negative staphylococci. In: Long S, Pickering L, Prober C, eds. Principles and Practice of Pediatric Infectious Diseases. New York: Churchill Livingstone, 1997: 793-801.
92. Puri J, Revathi G, Faridi MMA, Talwar V, Kumar A, Parkash B. Role of body surface cultures in prediction of sepsis in a neonatal intensive care unit. Ann Trop Pediatr 1995; 15:307-311.
93. Ghosh S, Chatterjee BD, Chakraborty CK, Chakravarty A, Khatua SP. Bacteria in surface infections in neonates. J Indian Med Assoc 1995; 93:132-135.
94. Bhutta ZA, Yusuf K. Early-onset neonatal sepsis in Pakistan: a case control study of risk factors in a birth cohort. Am J Perinatol 1997; 14:577-581.
95. Khan IA, Akram DS. Neonatal sepsis—etiologic study. J Pak Med Assoc 1987; 37:327-340.
96. Monga K, Fernandez A, Deodhar L. Changing bacteriological patterns in neonatal septicemia. Ind J Pediatr 1986; 53:505-508.
97. Sharma PP, Halder D, Dutta AK, Dutta R, Bhatnagar S, Bali A, Kumar S. Bacteriological profile of neonatal septicaemia. Indian Pediatr 1987; 24:1011-1017.
98. Rao PS, Baliga M, Shivananda PG. Bacteriology of neonatal septicemia in a rural referral hospital in South India. J Trop Pediatr 1993; 39:230-233.
99. Mir F, Aman S, Khan SR. Neonatal sepsis: a review with a study of 50 cases. J Trop Pediatr 1987; 33:131-135.
100. WHO Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. Pediatr Infect Dis J 1999; 18:S17-22.
101. Falkow S. Invasion and intracellular sorting of bacteria: searching for bacterial genes expressed during host/pathogen interactions. J Clin Invest 1997; 100:239-243.
102. Mengaud J, Ohayon H, Gounon P, Mege RM, Cossart P. E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell 1996; 84:923-932.
103. Finlay BB, Falkow S. Salmonella interactions with polarized human intestinal Caco-2 epithelial cells. J Infect Dis 1990; 162:1096-1106.
104. Isberg RR, Leong JM. Multiple B1 chain integrins are receptors for invasion, a protein that promotes bacterial penetration into mammalian cells. Cell 1990; 60:861-871.
105. Rubens CE, Smith S, Hulse M, Chi EY, van Belle G. Respiratory epithelial cell invasion by group B streptococci. Infect Immun 1992; 60:5157-5163.
106. LaPenta D, Rubens C, Chi E, Cleary PP. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci 1994; 91:12115-12119.
107. Schrager HM, Rheinwald JG, Wessels MR. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest 1996; 98:1954-1958.
108. Schrager HM, Wessels MR. Hyaluronic acid capsule modulates interactions of group A streptococci with human epidermal keratinocytes. Adv Exp Med Biol 1997; 418:517-523.
109. Darmstadt GL. Skin and Soft Tissue Infections. In: Long SS, Prober CG, Pickering LK, eds. Principles and Practice of Pediatric Infectious Disease. 2d ed. New York: Churchill Livingstone, 2002; in press.
110. Zittergruen M, Grose C. Magnetic resonance imaging for early detection of necrotizing fasciitis. Pediatr Emerg Care 1993; 9:26-28.
111. Dillon HC, Reeves MSA. Streptococcal immune responses in nephritis after skin infection. Am J Med 1974, 56:333-346.
112. Darmstadt GL, Dinulos JG. Neonatal skin care. Pediatr Clin North Am 2000; 47(4):757-782.
113. Silverman J, Vasquez JA, Sobel JD, Zervos MJ. Comparative in vitro activity of antiseptics and disinfectants versus clinical isolates of Candida species. Infect Cont Hosp 1999; 20:676-684.
114. Pelke S, Ching D, Easa D, Melish ME. Gowning does not affect colonization or infection rates in a neonatal intensive care unit. Arch Pediatr Adol Med 1994; 148:1016-1020.
115. Rangel-Frausto MS, Martin MA, Saiman L. High prevalence of Candida species on hands of health care workers (HCW) in surgical (S), neonatal N, an intensive care units (ICU): a multicenter study (abstr). 34th ICAAC, Orlando, FL, October 4-7, 1994.
116. Baley JE, Kliegman RM, Boxerbaum B, Faneroff AA. Fungal colonization in the very low birth weight infant. Pediatrics 1986; 78:225-232.
117. Huang YC, Li CC, Lin TY, Lien RI, Chou YH, Wu JL, Hsueh C. Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J 1998; 17(9):819-822.
118. Skewes SM. Skin care rituals that do more harm than good. Am J Nurs 1996; 96:33-35.
119. Franke LS, Quinn D, Zahr L. Effect of less frequent bathing of preterm infants on skin flora and pathogen colonization. J Obstet Gynecol Neonat Nurs 2000; 29(6):584-589.
120. Henningson A, Nystom B, Tunnel R. Bathing or washing babies after birth? Lancet 1981; 26:1401-1403.
121. World Health Organization. Essential Newborn Care: Report of a Technical Working Group. WHO/FRH/MSM/96.13, Geneva, Switzerland: WHO, 1996.
122. World Health Organization. Thermal Protection of the Newborn: A Practical Guide. WHO/RHT/MSM/97.2, Geneva, Switzerland: WHO, 1997.
123. Davies J, Babb JR, Ayliffe AJ. The effect on the skin flora of bathing with antiseptic solutions. J Antimicrob Chemother 1977; 3:473-481.
124. Lilly HA, Lowbury EJL, Wilkins MD. Detergents compared with each other and with antiseptics as skin ‘degerming’ agents. J Hygiene Cambridge 1979; 82:89-93.
125. Behrendt H, Green M. Patterns of Skin pH from Birth Through Adolescence. Springfield, IL: Charles C Thomas, 1971.
126. Fox CF, Nelson D, Wareham J. The timing of skin acidification in very low birth weight infants. J Perinatol 1998; 18:272-275.
127. Kuller JM, Lund CH. Assessment and management of integumentary dysfunction. In: Kenner C, Brueggemeyer A, Gunderson L, eds. Comprehensive Neonatal Nursing: A Physiologic Perspective. Philadelphia: WB Saunders, 1993:742-781.
128. Kuller JM, Lund C, Tobin C. Improved skin care for premature infants. Am J Mat Child Nurs 1983; 8:200-203.
129. Peck SM, Botwinick IS. The buffering capacity of infants skins against an alkaline soap and a neutral detergent. J Mount Sinai Hosp New York 1964; 31:134-137.
130. Buckingham KW, Berg RW. Etiologic factors in diaper dermatitis: the role of feces. Pediatr Dermatol 1986; 3:107-112.
131. Frosch PJ, Kligman AM. The soap chamber test: a new method for assessing the irritancy of soaps. Am Acad Dermatol 1979; 1:35-41.
132. Meduras JM. Does bathing newborns remove potentially harmful pathogens from the skin? Birth 2001; 1 (3):161-165.
133. Franck LS, Quinn D, Zahr L. Effect of less frequent bathing of preterm infants on skin flora and pathogen colonization. J Obstet Gynecol Neonatal Nurs 2000; 29(6):584-589.
134. Cowan ME, Frost MR. A comparison between a detergent baby bath additive and baby soap on the skin flora of neonates. J Hosp Infect 1986; 7:91-95.
135. Miller SJ, Aly R, Shinefield HR, Elias PM. In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol 1988; 124:209-215.
136. Als H, Lawhon G, Brown E, Gibes R, Duffy FH, McAnulty G, Blickman JG. Individualized behavioral and environmental care for the very low birth weight preterm infant at high risk for bronchpulmonary dysplasia: neonatal intensive care unit and developmental outcomes. Pediatrics 1986; 78:1123-1132.
137. Malloy MB. Skin care for high-risk neonates. J Wound Ost Continence Nurs 1995; 22:177-182.
138. Hylen AM, Karlsson E, Svanberg L, Walder M. Hygeine for the newborn: to bathe or to wash? J Hygeine 1983; 91:529-534.
139. Rush J. Does routine newborn bathing reduce Staphylococcus aureus colonization rates? A randomized controlled trial. Birth 1986; 13:176-180.
140. Biggar RJ, Miotti PG, Taha TE, Mtimavalye L, Broadhead R, Justesen A, Yellin F, Limba G, Miley W, Waters D, Chiphangwi JD, Goedert JJ. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996; 347:1647-1650.
141. Taha TE, Biggar RJ, Broadhead RL, Mtimavalye L, Justesen A, Limba G, Chiphangwi JD, Miotti PG. Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial. BMJ 1997; 315:216-220.
142. Adriaanse AH, Lollee LAA, Muytjens HL, Nijhuis JG, de Haan AF, Eskes TK. Randomized study of vaginal chlorhexidine disinfection during labor to prevent vertical transmission of group B streptococci. Eur J Obstet Gynecol 1995; 61:135-141.
143. Hendrichsen T, Lindemann R, Svenningsen L, Hjelle K. Prevention of neonatal infections by vaginal chlorhexidine disinfection during labour. Acta Paediatr 1994; 83:923-926.
144. Saijo S, Tagami H. Dry skin of newborn infants: functional analysis of the stratum corneum. Pediatr Dermatol 1991; 8:155-159.
145. Lane AT, Drost SS. Effects of repeated application of emollient cream to premature neonates’ skin. Pediatrics 1993; 92:415-419.
146. Campbell JR, Zaccaria E, Baker CJ. Systemic candidiasis in extremely low birth weight infants receiving topical petrolatum ointment for skin care: a case control study. Pediatrics 2000; 105(5):1041-1045.
147. Elias PM, Mao-Qiang M, Thornfeldt CR, Feingold KR. The epidermal permeability barrier: effects of physiologic and non-physiologic lipids. In: Hoppe U, ed. The Lanolin Book. Hamburg: Beiersdorf AG, 1999:253-279.
148. Mao-Qiang M, Feingold KR, Elias PM. Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol 1993;129:728-738.
149. Hanley K, Jiang Y, Crumrine D, Bass NM, Appel R, Elias PM, Williams ME, Feingold KR. Activators of the nuclear hormone receptors PPARa and FXR accelerate the development of the fetal epidermal permeability permeability barrier. J Clin Invest 1997; 100:705-712.
150. Hanley K, Jiang Y, He SS, Friedman M, Elias PM, Bikle DD, Williams ML, Feingold KR. Keratinocyte differentiation is stimulated by activators of the nuclear hormone receptor PPARα. J Invest Dermatol 1998; 110:368-775.
151. Bertone SA, Fisher MC, Mortensen JE. Quantitative skin cultures at potential catheter sites in neonates. Infect Control Hosp Epidemiol 1994; 15:315-318.
152. World Health Organization. Care of the Umbilical Cord: A Review of the Evidence. Geneva, Switzerland: WHO/RHT/MSM/98.4, 1994.
153. Garner P, Lai D, Baea M, Edwards K, Heywood P. Avoiding neonatal death: an intervention study of umbilical cord care. J Trop Pediatr 1994; 40:24-28.
154. Belfrage E, Enocksson E, Kalin M, Marland M. Comparative efficiency of chlorhexidine and ethanol in umbilical cord care. Scand J Infect Dis 1985; 17(4):413-420.
155. Smales O. A comparison of umbilical cord treatment in the control of superficial infection. NZ Med J 1988; 101:453-455.
156. Verber IG, Pagan FS. What cord care—if any? Arch Dis Child 1993; 68:594-596.
157. Gladstone IM, Clapper L, Thorpe JW, Wright DI. Randomized study of six umbilical cord care regimens. Clin Pediatr 1988; 27:127-129.
158. Dore S, Buchan D, Coulas S, Hamber L, Stewart M, Cowan D, Jamieson L. Alcohol versus natural drying for newborn cord care. JOGNN 1998; 27(6):621-627.
159. Paes B, Jones CC. An audit of the effect of two cord-care regimens on bacterial colonization in newborn infants. Qual Rev Bull 1987; 13:109-113.
160. Lacour J. Cord care: results of a survey from South-France and recommendations. Eur J Pediatr Dermatol 1998; 8:233-234.
161. Malathi I, Miller MR, Leeming JP, Hedges A, Marlow N. Skin disinfection in preterm infants. Arch Dis Child 1993; 69:312-316.
162. Garland JS, Buck RK, Maloney P, Durkin DM, Toth-Lloyd S, Duffy M, Szocik P, McAuliffe TL, Goldmann DA. Comparison of 10% povidoneiodine and chlorhexidine gluconate for the prevention of peripheral IV catheter colonization in neonates. A prospective trial. Pediatr Inf Dis J 1995; 14:510-516.
163. Garland JS, Alex CP, Mueller CD, Otten D, Shivpuric C, Harris MC, Naples M, Pellegrini J, Buck RK, McAuliffe TL, Goldmann DA, Maki DG. A randomized trial comparing povodine-iodine to a chlorhexidine-gluconate impregnated dressing for prevention of central venous catheter infection in neonates. Pediatrics 2001; 107(6):1431-1436.
164. Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter related coagulase negative staphylococcal sepsis in neonates. J Pediatr 1994; 125(2):259-263.